Olmesartan medoxomil
Side effects
Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | ||
|---|---|---|---|---|---|
| 1 | 2 | 3 | |||
| Abdominal pain | x | x | x | ||
| Alopecia | x | ||||
| Angioedema | x | x | |||
| Arthralgia | x | x | x | ||
| Arthritis | x | x | x | ||
| Asthenia | x | ||||
| Back pain | x | x | x | ||
| Mental disorder | x | ||||
| Bronchitis | x | x | x | ||
| Chest pain | x | x | x | ||
| Cough | x | x | x | ||
| Diarrhoea | x | x | x | ||
| Dizziness | x | x | x | ||
| Dyspepsia | x | x | x | ||
| Rash | x | x | x | ||
| Fatigue | x | ||||
| Gastroenteritis | x | x | x | ||
| Headache | x | x | x | ||
| Haematuria | x | x | x | ||
| Hypercholesterolaemia | x | x | x | ||
| Hyperglycaemia | x | x | x | ||
| Hyperlipidaemia | x | x | x | ||
| Hypertriglyceridaemia | x | x | x | ||
| Renal failure acute | x | ||||
| Nausea | x | x | x | ||
| Pain | x | ||||
| Pharyngitis | x | x | x | ||
| Pruritus | x | ||||
| Rhabdomyolysis | x | x | |||
| Rhinitis | x | x | x | ||
| Sinusitis | x | x | x | ||
| Tachycardia | x | x | x | ||
| Upper respiratory tract infection | x | ||||
| Urinary tract infection | x | ||||
| Urticaria | x | ||||
| Vertigo | x | x | x | ||
| Vomiting | x | ||||
| Oedema peripheral | x | x | x | ||
| Creatine phosphokinase increased | x | x | x | ||
| Bone pain | x | ||||
| Malnutrition | x | x | x | ||
| Myalgia | x | x | x | ||
| Blood creatinine increased | x | ||||
| Influenza-like symptoms | x | x | x | ||
| Transaminases increased | x | x | x | ||
| Face oedema | x | x | x | ||
| Inflicted injury | x | ||||
| Hyperuricaemia | x | x | x | ||
| Bilirubin value increased | x | x | x | ||
| Insomnia | x | ||||
Indications
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||
|---|---|---|---|---|---|
| Hypertension | x | x | x | ||
| Hypertensive | x | x | |||
Color scheme:
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |
